MedTrace Logo

The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy

NCT01795001 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 460

Last updated 2018-05-24

No results posted yet for this study

Summary

The purpose of this study is to gain further insights into the molecular pathogenesis of Fuchs' endothelial corneal dystrophy (FECD), to identify targets for potential specific drug therapy.

Conditions

  • Fuchs' Endothelial Dystrophy

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Fund for Scientific Research, Flanders, Belgium

    collaborator OTHER

  • Funds for Research in Ophthalmology, Belgium

    collaborator UNKNOWN

  • Mieke Perdaens fund for Eye Research

    collaborator UNKNOWN

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Joost J van den Oord, MD, PhD · KU Leuven

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2017-09-13
Completion
2017-09-13

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01795001 on ClinicalTrials.gov